Overview
Carol Dukes Hamilton, MD, MHS is a Professor of Medicine, Emeritus, in the Infectious Diseases Division, Department of Medicine, Duke University Medical Center. She has nearly 40 years of experience spanning clinical care, research, public health, and global leadership. She served as clinician and full-time faculty at Duke University Medical Center from 1991 until 2008, concentrating on outpatient and inpatient clinical care (HIV/AIDS, tuberculosis [TB], and routine infectious disease problems). She expanded the nascent Antibiotic Decision Support Team (ADST) and helped establish the Division’s research program in Dar es Salaam, and later Moshi, Tanzania. While at Duke, Dr. Hamilton led the North Carolina TB Control Program in Raleigh, from 2001-2008, serving as the TB Controller for the State. After achieving Full Professor, with Tenure status at Duke, she was recruited to Family Health International (now FHI 360) to lead development of their TB research portfolio of work, and subsequently led all TB programmatic work as well, working in numerous countries in sub-Saharan Africa (primarily Zambia, Mozambique and Nigeria), and Asia (primarily China, Myanmar, Indonesia, Cambodia), while maintaining her Duke affiliation as a Consulting Professor. She served in several leadership positions at FHI 360, including Director of Scientific Affairs in the largest unit, the Global Health, Population & Nutrition Group, where she oversaw the quality of research done globally in health and nutrition at the organization.
Dr. Hamilton has over 100 peer-reviewed publications, mostly focused on HIV/AIDS, TB and the intersection between the two diseases. Awards include the CDC’s Charles C. Shepard Science Award, the National TB Controllers Association’s Robert Koch Award, and the D. A. Henderson Award for Lifetime Achievement in Global Public Health from the Infectious Diseases Society of America. In 2024, the University of Utah School of Medicine awarded Carol their Distinguished Alumni Award. She is an Emeritus Professor of Medicine at Duke and leads a Career Path Series for Infectious Disease Fellows in the Duke ID Division.
Key words: Tuberculosis; mycobacteria other than TB (MOTT); HIV/AIDS; HAART; genomics; global health; public health;
Dr. Hamilton has over 100 peer-reviewed publications, mostly focused on HIV/AIDS, TB and the intersection between the two diseases. Awards include the CDC’s Charles C. Shepard Science Award, the National TB Controllers Association’s Robert Koch Award, and the D. A. Henderson Award for Lifetime Achievement in Global Public Health from the Infectious Diseases Society of America. In 2024, the University of Utah School of Medicine awarded Carol their Distinguished Alumni Award. She is an Emeritus Professor of Medicine at Duke and leads a Career Path Series for Infectious Disease Fellows in the Duke ID Division.
Key words: Tuberculosis; mycobacteria other than TB (MOTT); HIV/AIDS; HAART; genomics; global health; public health;
Current Appointments & Affiliations
Professor Emeritus of Medicine
·
2019 - Present
Medicine, Infectious Diseases,
Medicine
Recent Publications
Who Knew? Injectable TB Drugs Are Not Equal, Despite Drug Susceptibility Testing.
Journal Article Clin Infect Dis · December 6, 2021 Full text Link to item CiteThe China tuberculosis clinical trials consortium network: a model for international TB clinical trials capacity building.
Journal Article Infect Dis Poverty · May 15, 2020 BACKGROUND: With the second largest tuberculosis (TB) burden globally, China is committed to actively engage in international TB clinical trials to contribute to global TB research. However, lack of research capacity among local sites has been identified a ... Full text Link to item CiteOver- and under-treatment of TB patients in Eastern China: an analysis based on health insurance claims data.
Journal Article Trop Med Int Health · September 2019 OBJECTIVE: Poor compliance with existing guidelines for tuberculosis (TB) care and treatment is an issue of concern in China. We assessed health service use by TB patients over the entire treatment process and compared it to the recommended guidelines. MET ... Full text Link to item CiteRecent Grants
International Clinical Trials Unit
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2004 - 2009TB Clinical Research: Training the Next Generation
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2004 - 2008Enhancing the U.S. Public Health System's Willingness and Capacity to Engage in Clinical Research
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2004 - 2008View All Grants
Education, Training & Certifications
University of Utah ·
1985
M.D.